MedPath

A study to evaluate the effectiveness of vidanga(Embelia ribes) powder in the management of Gastritis caused by infection (Helicobacter pylori)

Phase 2
Not yet recruiting
Conditions
Other gastritis. Ayurveda Condition: AMLAPITTAM,
Registration Number
CTRI/2023/05/053006
Lead Sponsor
Dr S Maniziia
Brief Summary

This is a clinical study to evaluate the efficacy of Vidanga churna in the management of Urdhwaga amlapitta due to helicobacter pylori. This is done as a mandatory part of Post Graduation. Total number of 60 patients will be studied in 60 days each.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Symptoms- 1.Sour or bitter eructation/belching 2.nausea, pyrosis, water brash, 3.Indigestion,Loss of appetite 4.Gaseous distension, heaviness of body 5.Positive Helicobacter pylori in upper GI endoscopy yr.

Exclusion Criteria

1.Any Cancer of Gastrointestinal tract 2.Past history of Abdominal surgery 3.Pregnant and lactating mother 4.Patients of major systemic illness including Cardiac, hepatobiliary, kidney and IBS 5.Hiatus hernia 6.Major Oral pharyngeal and laryngeal infections.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To Decrease the symptoms of pyrosis,nausea,sour eructation, bloating, abdominal pain60 days
2.To improve digestion and appetite60 days
Secondary Outcome Measures
NameTimeMethod
Upper Gastrointestinal Endoscopy with negative H.pylori(RUT)60 days

Trial Locations

Locations (1)

Government Ayurvedic College and Hospital

🇮🇳

Kamrup, ASSAM, India

Government Ayurvedic College and Hospital
🇮🇳Kamrup, ASSAM, India
Dr S Maniziia
Principal investigator
7085712596
maniziiakayina56@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.